Document is current
Any future updates will be listed below
-
Authors
Chu, Hongyu
Xu, Yajun
Shan, Yuezhan
Sun, Mengmeng
Zhao, Weidong
Fang, Xuedong
Shen, Na
Tang, Zhaohui
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (52273157, 52073279, 52025035)
National Natural Science Foundation of Jilin Province (20230508102RC, 20240305041YY)
Youth Innovation Promotion Association of the Chinese Academy of Sciences (2022224)
Ministry of Science and Technology of China (2022YFE0110200)
- License Information
-
More Information
Article History
Received: 15 August 2024
Accepted: 20 February 2025
First Online: 10 March 2025
Declarations
:
: In vivo antitumor studies were performed in mice bearing CT26 colorectal or 4T1 breast cancer cells, adhering to the Guide for the Care and Use of Laboratory Animals. All protocols were approved by the Animal Care and Use Committee of the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences.
: The authors declare no competing interests.
